Literature DB >> 12860878

CD14 promoter polymorphism is associated with acute myocardial infarction resulting from insignificant coronary artery stenosis.

T Kondo, M Ohno, K Shimokata, S Iino, Y Inden, T Murohara, M Hirai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12860878      PMCID： PMC1767788          DOI： 10.1136/heart.89.8.931

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction.

Authors:  J A Hubacek; G Rothe; J Pit'ha; Z Skodová; V Stanĕk; R Poledne; G Schmitz
Journal:  Circulation       Date:  1999-06-29       Impact factor: 29.690

2.  A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction.

Authors:  R Y Zee; K Lindpaintner; B Struk; C H Hennekens; P M Ridker
Journal:  Atherosclerosis       Date:  2001-02-15       Impact factor: 5.162

3.  A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile.

Authors:  K Unkelbach; A Gardemann; M Kostrzewa; M Philipp; H Tillmanns; W Haberbosch
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

4.  Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men.

Authors:  K Shimada; Y Watanabe; H Mokuno; Y Iwama; H Daida; H Yamaguchi
Journal:  Am J Cardiol       Date:  2000-09-15       Impact factor: 2.778

5.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.

Authors:  P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245
  5 in total
  6 in total

1.  Critical investigation of the CD14 promoter polymorphism: lack of a role for in vitro cytokine response and membrane CD14 expression.

Authors:  Sonja von Aulock; Jan Rupp; Katja Gueinzius; Matthias Maass; Corinna Hermann
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

2.  A solute carrier family 22 member 3 variant rs3088442 G→A associated with coronary heart disease inhibits lipopolysaccharide-induced inflammatory response.

Authors:  Lu Li; Meian He; Li Zhou; Xiaoping Miao; Fangqing Wu; Suli Huang; Xiayun Dai; Tian Wang; Tangchun Wu
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

Review 3.  CD14 and toll-like receptor 4: a link between infection and acute coronary events?

Authors:  R Arroyo-Espliguero; P Avanzas; S Jeffery; J C Kaski
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

4.  Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease.

Authors:  Zhiyong Chen; Megumi Takahashi; Taeko Naruse; Toshiaki Nakajima; Yi-Wen Chen; Yoshinori Inoue; Isao Ishikawa; Takehisa Iwai; Akinori Kimura
Journal:  Hum Genet       Date:  2007-07-25       Impact factor: 4.132

5.  Risk of Atherosclerosis and Helicobacter pylori Infection according to CD14 Promotor Polymorphism in Healthy Korean Population.

Authors:  Sung-Goo Kang; Woo Chul Chung; Sang-Wook Song; Kyu Re Joo; Hyewon Lee; Donghoon Kang; Joune Seup Lee; Kang-Moon Lee
Journal:  Gastroenterol Res Pract       Date:  2013-10-21       Impact factor: 2.260

6.  Collapsing the list of myocardial infarction-related differentially expressed genes into a diagnostic signature.

Authors:  German Osmak; Natalia Baulina; Philipp Koshkin; Olga Favorova
Journal:  J Transl Med       Date:  2020-06-09       Impact factor: 5.531
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.